Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients

NCT01152385 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

224

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: AZD1656
DRUG: Placebo

Sponsor

AstraZeneca